InvestorsHub Logo
Followers 116
Posts 1927
Boards Moderated 0
Alias Born 11/22/2017

Re: ATLnsider post# 539275

Sunday, 11/27/2022 11:53:14 AM

Sunday, November 27, 2022 11:53:14 AM

Post# of 721937
October 27, 2022

Linda Liau

"This is our next SPORE trial (DC vaccine/poly-ICLC + anti-PD1 + CSF1-Ri in newly diagnosed GBM patients) but we haven't started it yet."

anti-PD1= Pembrolizumab 400 mg q 6 weeks.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News